The Food Allergy Institute (FAI) today announced the publication of a peer-reviewed paper authored by its founder, Inderpal Randhawa, MD, in the clinical journal PLOS ONE. The paper titled “Compilation of Food Anaphylaxis Diagnostic Markers in Machine Learning Design and Validation” is co-authored with data scientist Kirill GroschenkovGrigori Sigalov is the first peer-reviewed study to analyze the role and effectiveness of machine learning in actively treating patients with severe food allergies.
“We are delighted to share our research,” said Dr. Landawa. It was published through the PLOS ONE journal.” “The therapy used, the Tolerance Induction Program (TIP), is a clinical care model steeped in data science and machine learning innovations for treating patients with severe food allergies. more than 100,000 patients have been in remission from food anaphylaxis, and AI is central to each successful and unique patient care experience.”
Since 2007, the Institute’s founder and CEO, Dr. Inderpal Randhawa, has prioritized applied mathematics, machine learning design and artificial intelligence, utilizing trillions of data points and datasets to create personalized medicine for each patient. I have established a program.
“We now have over a decade of machine learning and AI experience,” said Dr. Randhawa. “The specific construction and application of AI to treat food anaphylaxis has yielded surprisingly consistent and clear results. You leave the program feeling free of what you were in: food allergies that used to be deadly. All this thanks to constantly evolving machine learning. ”
Applied mathematics and AI designed, analyzed, enhanced and optimized at the Food Allergy Institute have led to newly published research after more than a decade of hard work. Utilizing a proprietary end-to-end data system, the Food Allergy Institute guides patients from the initiation of tolerance induction programs to years of remission. This is driven by the data assortment and dynamics that lead to clinical experiences that are enhanced every day.
“You often hear the phrase ‘bench to bedside’ to describe how science brings research to patients,” added Dr. Randhawa. “With the TIP methodology we are pioneering at the Food Allergy Institute, our patients are directly integrated into our machine learning and AI systems, providing research science and clinical care on a daily basis as patients reach and maintain remission. It is challenging to demonstrate, through published peer-reviewed research, this cross-section of applied mathematics meets medicine and the significant improvement in quality of life that patients and their families are experiencing as a result. there is.”
“The publication of this study is a precursor to the pending FDA submission seeking approval of TIP as a medical model,” added Dr. Randhawa. “With the 20 trillion data points we have collected, we are able to develop a treatment plan that safely treats each patient’s unique food allergy with an individualized treatment plan. Ultimately, we are excited to further explore the frontier of what we believe to be an innovative approach to the clinical treatment of many other conditions.”
Founded in 2015 by Inderpal Randhawa, MD, the Food Allergy Institute is a leading-edge clinical care and research center revolutionizing food allergy treatment. Built on diagnostic data collected over a decade, the Food Allergy Institute’s Tolerance Induction Program (TIP) is a professional treatment program designed to help children with food allergies achieve “Food Freedom.” is. Unlimited amount, without fear of reaction. The Food Allergy Institute currently has locations in Long Beach and San Diego, with more locations scheduled to open later this year.Click here for details foodallergyinstitute.com
View source version at businesswire.com: https://www.businesswire.com/news/home/20230405005724/en/
